Elanco Animal Health Incorporated ( ELAN) - Stock Earnings
ELAN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 6, 2026, midnight | — / — | — | — / — | — |
ELAN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -276.0 million USD | 1.1 billion USD |
| 2026Q1 | 57.0 million USD | 1.4 billion USD |
| 2026Q2 | 54.0 million USD | 1.4 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ELAN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -1.2 billion USD | 4.4 billion USD |
| 2024 | 338.0 million USD | 4.4 billion USD |
| 2025 | -232.0 million USD | 4.7 billion USD |
| 2026 Est. | — | — |
ELAN
Price: $22.41
Earnings Per Share: -0.41 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 5.1 million
Market Capitalization: 11.1 billion